Follow
Shuming Zhang
Shuming Zhang
Verified email at jhu.edu
Title
Cited by
Cited by
Year
Integrating single cell sequencing with a spatial quantitative systems pharmacology model spQSP for personalized prediction of triple-negative breast cancer immunotherapy response
S Zhang, C Gong, A Ruiz-Martinez, H Wang, E Davis-Marcisak, ...
Immunoinformatics 1, 100002, 2021
222021
Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence
S Zhang, L Yuan, L Danilova, G Mo, Q Zhu, A Deshpande, ATF Bell, ...
bioRxiv, 2023.01. 10.523481, 2023
202023
Uncovering the spatial landscape of molecular interactions within the tumor microenvironment through latent spaces
A Deshpande, M Loth, DN Sidiropoulos, S Zhang, L Yuan, ATF Bell, ...
Cell systems 14 (4), 285-301. e4, 2023
142023
Informing virtual clinical trials of hepatocellular carcinoma with spatial multi-omics analysis of a human neoadjuvant immunotherapy clinical trial
S Zhang, A Deshpande, BK Verma, H Wang, H Mi, L Yuan, WJ Ho, ...
bioRxiv, 2023
52023
Leveraging multi-omics data to empower quantitative systems pharmacology in immuno-oncology
T Arulraj, H Wang, A Ippolito, S Zhang, EJ Fertig, AS Popel
Briefings in bioinformatics 25 (3), bbae131, 2024
2024
Integrating spatial multi-omics data with spatial quantitative pharmacology (spQSP) model to simulate human neoadjuvant immunotherapy clinical trial of hepatocellular carcinoma
S Zhang, A Deshpande, BK Verma, H Wang, H Mi, L Yuan, WJ Ho, ...
Cancer Research 84 (6_Supplement), 2312-2312, 2024
2024
Spatial transcriptomics of advanced hepatocellular carcinomas distinguishes intercellular interactions in responders and non-responders to cabozantinib and nivolumab …
LT Kagohara, S Zhang, L Yuan, Q Zhu, R Anders, D Shu, AS Popel, ...
Cancer Research 82 (12_Supplement), 3820-3820, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–7